795 related articles for article (PubMed ID: 26857878)
21. What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women.
Hickey M; Trainer A; Braat S; Davey MA; Krejany E; Wark J
BMJ Open; 2017 Nov; 7(11):e018758. PubMed ID: 29138210
[TBL] [Abstract][Full Text] [Related]
22. Relationship satisfaction predicts sexual activity following risk-reducing salpingo-oophorectomy.
Lorenz T; McGregor B; Swisher E
J Psychosom Obstet Gynaecol; 2014 Jun; 35(2):62-8. PubMed ID: 24693956
[TBL] [Abstract][Full Text] [Related]
23. Surgical Menopause and Bilateral Oophorectomy: Effect of Estrogen-Progesterone and Testosterone Replacement Therapy on Psychological Well-being and Sexual Functioning; A Systematic Literature Review.
Stuursma A; Lanjouw L; Idema DL; de Bock GH; Mourits MJE
J Sex Med; 2022 Dec; 19(12):1778-1789. PubMed ID: 36175351
[TBL] [Abstract][Full Text] [Related]
24. Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review.
Finch A; Narod SA
Maturitas; 2011 Nov; 70(3):261-5. PubMed ID: 21893388
[TBL] [Abstract][Full Text] [Related]
25. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
Finch A; Metcalfe KA; Chiang JK; Elit L; McLaughlin J; Springate C; Demsky R; Murphy J; Rosen B; Narod SA
Gynecol Oncol; 2011 Apr; 121(1):163-8. PubMed ID: 21216453
[TBL] [Abstract][Full Text] [Related]
26. Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention.
Bober SL; Recklitis CJ; Bakan J; Garber JE; Patenaude AF
J Sex Med; 2015 Jan; 12(1):189-97. PubMed ID: 25311333
[TBL] [Abstract][Full Text] [Related]
27. LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause.
Nappi RE; Lello S; Melis GB; Albani F; Polatti F; Genazzani AR
Climacteric; 2009 Dec; 12(6):533-40. PubMed ID: 19905905
[TBL] [Abstract][Full Text] [Related]
28. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
[TBL] [Abstract][Full Text] [Related]
29. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women.
Dennerstein L; Koochaki P; Barton I; Graziottin A
J Sex Med; 2006 Mar; 3(2):212-22. PubMed ID: 16490014
[TBL] [Abstract][Full Text] [Related]
30. Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
Gaba F; Blyuss O; Chandrasekaran D; Osman M; Goyal S; Gan C; Izatt L; Tripathi V; Esteban I; McNicol L; Ragupathy K; Crawford R; Evans DG; Legood R; Menon U; Manchanda R
BJOG; 2021 Mar; 128(4):714-726. PubMed ID: 32803845
[TBL] [Abstract][Full Text] [Related]
31. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
Benshushan A; Rojansky N; Chaviv M; Arbel-Alon S; Benmeir A; Imbar T; Brzezinski A
Climacteric; 2009 Oct; 12(5):404-9. PubMed ID: 19479488
[TBL] [Abstract][Full Text] [Related]
32. Influence of prophylactic oophorectomy on mood and sexual function in women of menopausal transition or postmenopausal period.
Chen X; Guo T; Li B
Arch Gynecol Obstet; 2013 Nov; 288(5):1101-6. PubMed ID: 23625334
[TBL] [Abstract][Full Text] [Related]
33. The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause.
Pezaro C; James P; McKinley J; Shanahan M; Young MA; Mitchell G
Fam Cancer; 2012 Sep; 11(3):403-10. PubMed ID: 22477030
[TBL] [Abstract][Full Text] [Related]
34. Impact of risk-reducing salpingo-oophorectomy in premenopausal women.
Vermeulen RFM; Beurden MV; Korse CM; Kenter GG
Climacteric; 2017 Jun; 20(3):212-221. PubMed ID: 28509627
[TBL] [Abstract][Full Text] [Related]
35. Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers.
Gaba F; Manchanda R
Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():46-65. PubMed ID: 32192936
[TBL] [Abstract][Full Text] [Related]
36. Psychological and sexual aspects of the menopause and HRT.
Pearce MJ; Hawton K
Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):385-99. PubMed ID: 8931901
[TBL] [Abstract][Full Text] [Related]
37. What happens after menopause? (WHAM): A prospective controlled study of sleep quality up to 12 months after premenopausal risk-reducing salpingo-oophorectomy.
Hickey M; Moss KM; Krejany EO; Wrede CD; Domchek SM; Kirk J; Brand A; Trainer A; Mishra GD; Baker FC
Gynecol Oncol; 2021 Aug; 162(2):447-453. PubMed ID: 34116835
[TBL] [Abstract][Full Text] [Related]
38. Coping with menopausal symptoms: An internet survey of Belgian postmenopausal women.
Depypere H; Pintiaux A; Desreux J; Hendrickx M; Neven P; Marchowicz E; Albert V; Leclercq V; Van den Branden S; Rozenberg S
Maturitas; 2016 Aug; 90():24-30. PubMed ID: 27282790
[TBL] [Abstract][Full Text] [Related]
39. The impact of bilateral salpingo-oophorectomy on sexuality and quality of life in women with breast cancer.
Tucker PE; Cohen PA; Bulsara MK; Jeffares S; Saunders C
Support Care Cancer; 2021 Jan; 29(1):369-375. PubMed ID: 32367228
[TBL] [Abstract][Full Text] [Related]
40. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer.
Elit L; Esplen MJ; Butler K; Narod S
Fam Cancer; 2001; 1(3-4):149-56. PubMed ID: 14574171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
